Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS (PLACATE-MS)

This study has been terminated.
(funding stopped due to slow enrollment.)
Sponsor:
Information provided by (Responsible Party):
Andrew Goodman, University of Rochester
ClinicalTrials.gov Identifier:
NCT00638196
First received: March 10, 2008
Last updated: August 7, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)